Literature DB >> 3162407

Intraarticular and intraperitoneal administration of etoposide in haematological malignancy.

T J Littlewood1, A P Lydon, F Booth.   

Abstract

Etoposide is frequently used in the treatment of a wide variety of malignant disorders. Administration is usually by intravenous infusion, but etoposide can also be given by mouth, by intraarterial infusion and by direct instillation into the pleural cavity. Two patients are described who were treated with injections of etoposide into the peritoneal cavity and knee joint, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162407     DOI: 10.1007/bf00257368

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  4 in total

1.  Delayed toxicity of epipodophyllotoxin derivatives (VM 26 and VP 16-213), due to a local effect.

Authors:  H Stähelin
Journal:  Eur J Cancer       Date:  1976-11       Impact factor: 9.162

Review 2.  Review of etoposide.

Authors:  N C Phillips; R D Lauper
Journal:  Clin Pharm       Date:  1983 Mar-Apr

3.  A case report and description of the pharmacokinetic behavior of intrapleurally instilled etoposide.

Authors:  J M Jones; E A Olman; M J Egorin; J Aisner
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

4.  Intra-arterial infusion therapy for pulmonary tumours.

Authors:  O Kokron; F Olbert
Journal:  Recent Results Cancer Res       Date:  1983
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.